Todd Franklin Watanabe, President and CEO at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,000 shares at $21.06 ($21K) on 2022-06-06, disclosed to the SEC on 2022-06-06.
Scheduled sale ($21k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |